Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

1 month ago 4
ARTICLE AD BOX
Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug Administration request to halt shipments of a gene therapy.
Read Entire Article
  1. Homepage
  2. Finance
  3. Sarepta Therapeutics’ stock slips further as company bows to FDA pressure to halt shipments

Related

How can I spend $5,000 to $10,000 a year on travel without wrecking my finances?

How can I spend $5,000 to $10,000 a year on travel without w...

28 minutes ago 0
Elon Musk’s xAI Sues Apple and OpenAI Over App Store Rankings

Elon Musk’s xAI Sues Apple and OpenAI Over App Store Ranking...

2 hours ago 0
Will Figma’s stock keep riding the AI hype? Wall Street isn’t so sure.

Will Figma’s stock keep riding the AI hype? Wall Street isn’...

3 hours ago 0

Trending

1. alexander isak
2. anthony gordon
3. bronson reed
4. tiafoe
5. raiders depth chart
6. usa
7. usa network
8. liverpool fc
9. jakobi meyers
10. sling

Popular

Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

6 months ago 271
Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

5 months ago 244
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

6 months ago 231
Steam will label early access games that haven't been updated in a year

Steam will label early access games that haven't been update...

6 months ago 231
Google's Magic Editor will watermark its AI-tweaked photos

Google's Magic Editor will watermark its AI-tweaked photos

6 months ago 218
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved